Clinical Risk Factors for SevereClostridium difficile–associated Disease
Open Access
- 1 March 2009
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 15 (3) , 415-422
- https://doi.org/10.3201/eid1503.080312
Abstract
Identifying patients who are at high risk for severe Clostridium difficile-associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes. Therefore, we compared clinical features associated with severe versus nonsevere CDAD by retrospectively reviewing records of hospitalized patients whose fecal assays were positive for C. difficile toxin. Of 336 patients, 12.2% had severe disease and 10.1% died from all causes. Regression modeling showed the following to be significantly associated with severe CDAD (p< or =0.05): age >70 years (odds ratio [OR] 3.35), maximum leukocyte count >20,000 cells/mL (OR 2.77), minimum albumin level 2 mg/dL (OR 2.47), small bowel obstruction or ileus (OR 3.06), and computed tomography scan showing colorectal inflammation (OR 13.54). These clinical and laboratory markers for severe disease may be useful for identifying patients at risk for serious outcomes or death.Keywords
This publication has 27 references indexed in Scilit:
- Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–PositiveClostridium difficileInfection Control & Hospital Epidemiology, 2007
- Clostridium difficile: changing epidemiology and new treatment optionsCurrent Opinion in Infectious Diseases, 2007
- Toxin Profiles and Resistances to Macrolides and Newer Fluoroquinolones as Epidemicity Determinants of Clinical Isolates of Clostridium difficile from Warsaw, PolandJournal of Clinical Microbiology, 2007
- Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent StrainAnnals of Surgery, 2007
- Severity of Clostridium difficile–Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading SystemInfection Control & Hospital Epidemiology, 2007
- Update on Emerging Infections From the Centers for Disease Control and PreventionAnnals of Emergency Medicine, 2006
- Continuation of Antibiotics Is Associated With Failure of Metronidazole for Clostridium difficile-Associated DiarrheaJournal of Clinical Gastroenterology, 2006
- Emergence of Clostridium difficile-associated disease in North America and EuropeClinical Microbiology & Infection, 2006
- Specific risk factors for Clostridium difficile-associated diarrhea: A prospective, multicenter, case control evaluationAmerican Journal of Infection Control, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004